compromised immunity
Conditions
Interventions
Trial group:Polypeptide Protein Immunobooster (IB-01)
Sponsors
Shulan (Boao) Hospital
Eligibility
Sex/Gender
All
Age
20 Years to 65 Years
Inclusion criteria
Inclusion criteria: (1) People aged between 20 and 65 (80% between 40 and 65); (2) Those who are weak and easy to get sick (meet 1 of them) : ? Colds =3 times per year; ?Bronchitis or pneumonia =2 times per year; ?Acute diarrhea (except lactose, wheat gum and other food intolerance) =3 times per year; ?Urinary tract infection =3 times per year; (3) Sign informed consent.
Exclusion criteria
Exclusion criteria: (1) Patients with immune dysfunction or serious blood system diseases, patients with advanced tumors and other serious underlying diseases, Such as systemic lupus erythematosus, rheumatoid arthritis, systemic vasculitis, scleroderma, pemphigus, dermatomyositis, mixed connective tissue disease, primary platelet purpura, autoimmune hemolytic anemia, Hashimoto's thyroiditis, primary myxedema, hyperthyroidism, ulcerative colitis and so on. (2) Allergic to multiple drugs or known components of the product of this study; (3) Women who are pregnant and planning for pregnancy in half a year, pregnant or lactating. (4) The chief complaint is unclear or has a history of epilepsy or central nervous system dysfunction, there are mental disorders can not cooperate; (5) Patients with severe diseases such as serious occupational diseases; (6) Patients with serious diseases of the heart, brain, liver, kidney and hematopoietic system;
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Safety and tolerability; | — |
Secondary
| Measure | Time frame |
|---|---|
| Antigen-specific immune response;Detection of T cell subsets;T cell receptor sequencing; | — |
Countries
China
Contacts
Public ContactZhongwei Wang
Shulan (Boao) Hospital
Outcome results
None listed